Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072).-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072).

Published:2015-05-20 Issue:15_suppl Volume:33 Page:4002-4002
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Alderson Derek¹,Langley Ruth E²,Nankivell Matthew Guy³,Blazeby Jane M.⁴,Griffin Michael⁵,Crellin Adrian⁶,Grabsch Heike I.⁷,Okines Alicia Frances Clare⁸,Goldstein Cindy⁹,Falk Stephen¹⁰,Thompson Joyce¹¹,Krysztopik Richard¹²,Coxon Fareeda Y.¹³,Pritchard Susan¹⁴,Langer Rupert¹⁵,Stenning Sally Patricia²,Cunningham David¹⁶

Affiliation:

1. Queen Elizabeth Hospital, Birmingham, United Kingdom

2. Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom

3. Medcl Rsrch Council, London, United Kingdom

4. University of Bristol, Bristol, United Kingdom

5. Royal Victoria Infirmary, Newcastle, United Kingdom

6. St James Institute of Oncology, Leeds, United Kingdom

7. Leeds Institute of Cancer Studies and Pathology, University of Leeds, Leeds, United Kingdom

8. Royal Mardsen Hospital, London, United Kingdom

9. MRC Clinical Trials Unit at UCL, London, United Kingdom

10. Yeovil District Hospital, Yeovil, United Kingdom

11. Birmingham Heartlands Hospital, Birmingham, United Kingdom